Taken together, miR-330-3p, acting as a promoter of NSCLC metastasis, may, by activating MAPK/ERK signaling pathway, induce 5′ CpG hypermethylation of GRIA3 and lead to the down-regulation of GRIA3 expression. This evidence concerns the gene GRIA3 and non-small cell lung carcinoma.